Market Tracker

11/25 6:05pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

5.78
Data as of Nov 25
 -0.09 / -1.53%
Today’s Change
3.11
Today|||52-Week Range
7.82
+2.66%
Year-to-Date

Today’s Trading

Previous close5.87
Today’s open5.90
Day’s range5.76 - 6.00
Volume3,198,344
Average volume (3 months)4,565,327
Market cap$723.0M
Dividend yield--
Data as of 3:59pm ET, 11/25/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+88.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book14.72

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.27+3.52%
OMEROmeros Corp+1.09+5.26%
INSMInsmed Inc+0.04+0.28%
RGENRepligen Corp-0.14-0.61%
Data as of 4:00pm ET, 11/25/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts